Analyst Ratings for Cytokinetics (CYTK)
CYTK Rating Summary
CYTK Price Target Summary
- Highest: $136.00 (H.C. Wainwright)
- Lowest: $67.00 (BofA Securities)
- Average: $89.73
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$89.73 (+48.5%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
Avg. $ Target:
$89.73 (+48.5%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays | Hang Hu | New Coverage | Overweight (N/A) |
87.00 (N/A) |
63.19 (60.41) |
-4.4% | Details |
| 12/18/2025 | Goldman Sachs | Paul Choi | Upgrade | Buy (Neutral) |
95.00 (N/A) |
59.82 (60.41) |
0.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
